Document is current
Any future updates will be listed below
-
Authors
Mehravar, Sepideh
Yeo, Yee Hui https://orcid.org/0000-0002-2703-5954
Pimentel, Mark
Naji, Parnian
Ng, Wee Han
Burger, Nils
Takakura, Will
Rezaie, Ali https://orcid.org/0000-0002-0106-372X
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 23 February 2026
First Online: 8 April 2026
Competing interests
: These authors disclose the following: Mark Pimentel is also a consultant for and received grant support from Bausch Health. Ali Rezaie reports serving as a consultant for Bausch Health and Ardelyx. In addition, Cedars-Sinai Medical Center has a licensing agreement with Gemelli Biotech. Ali Rezaie and Mark Pimentel have equity in Gemelli Biotech and Good LFE. The remaining authors disclose no conflicts.
